Udagawa H, Nilsson MB, Robichaux JP, He J, et al. HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies. J Thorac Oncol 2024;19:106-118.
PMID: 37678511